SCHEMBL32676015

SCHEMBL32676015

Cc1noc(C)c1COc1cccc(CNC(=O)c2ccc3ccccc3n2)c1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.62
TSHR P16473 2/20 0.60
ATM Q13315 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
LMNA P02545 4/20 0.55
AKR1C3 P42330 7/20 0.54
MAPT P10636 4/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
NOD2 Q9HC29 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
ALDH1A1 P00352 3/20 0.52
POLB P06746 1/20 0.49
MDM2 Q00987 1/20 0.49
MAPK1 P28482 2/20 0.49
KDM4E B2RXH2 1/20 0.49
RAB9A P51151 1/20 0.49
ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32676013 0.92 AKR1C3 (0.56) HPGDTSHRATMNPSR1LMNA
SCHEMBL32676006 0.85 ALDH1A1 (0.63) HPGDTSHRATMNPSR1LMNA
SCHEMBL30835869 0.84 ALDH1A1 (0.62) HPGDTSHRATMNPSR1LMNA
SCHEMBL30835871 0.78 ALDH1A1 (0.55) HPGDTSHRATMNPSR1LMNA
SCHEMBL32676007 0.76 ALDH1A1 (0.51) HPGDTSHRATMNPSR1LMNA
SCHEMBL32676012 0.76 ALDH1A1 (0.51) HPGDTSHRATMNPSR1LMNA
SCHEMBL32676017 0.75 LMNA (0.50) HPGDTSHRATMNPSR1LMNA
SCHEMBL32676009 0.75 ALDH1A1 (0.70) HPGDTSHRATMNPSR1LMNA
SCHEMBL30835951 0.74 MAPT (0.49) HPGDTSHRATMNPSR1LMNA
SCHEMBL32676014 0.74 ALDH1A1 (0.49) HPGDTSHRATMNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049064-A1 PROTEIN:PROTEIN INTERACTION INHIBITORS PURDUE RESEARCH FOUNDATION (US) 2026-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049064-A1 PROTEIN:PROTEIN INTERACTION INHIBITORS PRMT6, PRMT5, PRMT1 HPGD 4323/4885TSHR 2768/4885ATM 1367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.